Skip to main content
Caplight Logo









Zafrens

Zafrens

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://www.zafrens.com/

Last Round

Series A

Feb 4, 2025

Total Funding Raised

$71.16M

Company Overview

Zafrens is a biotechnology company that develops an ultra-high throughput platform for single-cell analysis and drug discovery by integrating biology, chemistry, and engineering.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

single-cell analysisdrug discoverymicrofluidicshigh-throughput screeningbiotech platformsingle-cell sequencingfunctional genomicsproteomicstherapeutic lead identificationlab automationsingle-cell multi-omicsdrug discovery techbiotech R&Ddata as a serviceDaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Zafrens Comparables

Compare Zafrens with similar companies based on industry and business-model similarity.

Zafrens comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Singleron Biotechnologies
77%
Mission Bio
76%
Bruker
72%

Zafrens Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AFeb 4, 2025
Series ADec 11, 2023
SeedDec 30, 2021

Zafrens Investors

Notable investors and investment history

Zafrens investors
InvestorRounds
Iaso VenturesSeries A
KOFA HealthcareSeries A
BlueYard CapitalSeries A
FoundersX VenturesSeries A
Global Brain CorporationSeries A
Alix VenturesSeries A
Hawktail ManagementSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 4, 2025

    $31M round with participation from BlueYard Capital and others.

  • Dec 11, 2023

    $31M round led by Prime Movers Lab.

Zafrens Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Zafrens Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Zafrens's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range29
Year Founded2021
Last FundingFeb 4, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?